|
|
Article: Discovery Biotech Files Registration Statement with the United States Securities Exchange Commission. (SEC); Document Control Number: 34SSR-002-07.
- Article from:
- PR Newswire
- Article date:
- April 25, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BURLINGTON, ON -- BURLINGTON, ON, April 17 /PRNewswire/ -- Discovery Biotech Files Registration Statement with the United States Securities Exchange Commission. (SEC)
Discovery Biotech is pleased to announce that it has filed a Form 1-A registration statement with the Securities Exchange commission. The current file proposes the registration to raise $5,000,000 USD via the sale of 400,000 shares of its common stock with a proposed offering price of $12.50 USD through an Initial Public Offering. The company warns readers that this in no way means the company has been listed or approved for listing on any exchange.
The Companys' President, Bernard ...